Literature DB >> 27646291

Rodent models of obsessive compulsive disorder: Evaluating validity to interpret emerging neurobiology.

Isaac Zike1, Tim Xu2, Natalie Hong3, Jeremy Veenstra-VanderWeele4.   

Abstract

Obsessive Compulsive Disorder (OCD) is a common neuropsychiatric disorder with unknown molecular underpinnings. Identification of genetic and non-genetic risk factors has largely been elusive, primarily because of a lack of power. In contrast, neuroimaging has consistently implicated the cortico-striatal-thalamo-cortical circuits in OCD. Pharmacological treatment studies also show specificity, with consistent response of OCD symptoms to chronic treatment with serotonin reuptake inhibitors; although most patients are left with residual impairment. In theory, animal models could provide a bridge from the neuroimaging and pharmacology data to an understanding of pathophysiology at the cellular and molecular level. Several mouse models have been proposed using genetic, immunological, pharmacological, and optogenetic tools. These experimental model systems allow testing of hypotheses about the origins of compulsive behavior. Several models have generated behavior that appears compulsive-like, particularly excessive grooming, and some have demonstrated response to chronic serotonin reuptake inhibitors, establishing both face validity and predictive validity. Construct validity is more difficult to establish in the context of a limited understanding of OCD risk factors. Our current models may help us to dissect the circuits and molecular pathways that can elicit OCD-relevant behavior in rodents. We can hope that this growing understanding, coupled with developing technology, will prepare us when robust OCD risk factors are better understood.
Copyright © 2016 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  autism; autoimmune; basal ganglia; optogenetic; repetitive behavior; striatum

Mesh:

Year:  2016        PMID: 27646291      PMCID: PMC5458638          DOI: 10.1016/j.neuroscience.2016.09.012

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  168 in total

1.  Lack of association between SLITRK1var321 and Tourette syndrome in a large family-based sample.

Authors:  J M Scharf; P Moorjani; J Fagerness; J V Platko; C Illmann; B Galloway; E Jenike; S E Stewart; D L Pauls
Journal:  Neurology       Date:  2008-04-15       Impact factor: 9.910

2.  Compulsions, Parkinson's disease, and stimulation.

Authors:  Luc Mallet; Valérie Mesnage; Jean-Luc Houeto; Antoine Pelissolo; Jérôme Yelnik; Cécile Behar; Marcella Gargiulo; Marie-Laure Welter; Anne-Marie Bonnet; Bernard Pillon; Philippe Cornu; Didier Dormont; Bernard Pidoux; Jean-François Allilaire; Yves Agid
Journal:  Lancet       Date:  2002-10-26       Impact factor: 79.321

3.  Anxiety in a transgenic mouse model of cortical-limbic neuro-potentiated compulsive behavior.

Authors:  M J McGrath; K M Campbell; M B Veldman; F H Burton
Journal:  Behav Pharmacol       Date:  1999-09       Impact factor: 2.293

Review 4.  Multiple rare SAPAP3 missense variants in trichotillomania and OCD.

Authors:  S Züchner; J R Wendland; A E Ashley-Koch; A L Collins; K N Tran-Viet; K Quinn; K C Timpano; M L Cuccaro; M A Pericak-Vance; D C Steffens; K R Krishnan; G Feng; D L Murphy
Journal:  Mol Psychiatry       Date:  2009-01       Impact factor: 15.992

5.  Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder.

Authors:  S Evelyn Stewart; Jesen A Fagerness; Jill Platko; Jordan W Smoller; Jeremiah M Scharf; Cornelia Illmann; Eric Jenike; Nadia Chabane; Marion Leboyer; Richard Delorme; Michael A Jenike; David L Pauls
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-12-05       Impact factor: 3.568

6.  Effect of subthalamic nucleus stimulation on obsessive-compulsive disorder in a patient with Parkinson disease. Case report.

Authors:  Denys Fontaine; Vianney Mattei; Michel Borg; Daniel von Langsdorff; Marie-Noelle Magnie; Stéphane Chanalet; Philippe Robert; Philippe Paquis
Journal:  J Neurosurg       Date:  2004-06       Impact factor: 5.115

7.  Cognitive deficits of executive functions and decision-making in obsessive-compulsive disorder.

Authors:  Winand H Dittrich; Thomas Johansen
Journal:  Scand J Psychol       Date:  2013-07-10

8.  Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder.

Authors:  Stella J de Wit; Pino Alonso; Lizanne Schweren; David Mataix-Cols; Christine Lochner; José M Menchón; Dan J Stein; Jean-Paul Fouche; Carles Soriano-Mas; Joao R Sato; Marcelo Q Hoexter; Damiaan Denys; Takashi Nakamae; Seiji Nishida; Jun Soo Kwon; Joon Hwan Jang; Geraldo F Busatto; Narcís Cardoner; Danielle C Cath; Kenji Fukui; Wi Hoon Jung; Sung Nyun Kim; Euripides C Miguel; Jin Narumoto; Mary L Phillips; Jesus Pujol; Peter L Remijnse; Yuki Sakai; Na Young Shin; Kei Yamada; Dick J Veltman; Odile A van den Heuvel
Journal:  Am J Psychiatry       Date:  2014-03       Impact factor: 18.112

9.  Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice.

Authors:  Sergey V Shmelkov; Adília Hormigo; Deqiang Jing; Catia C Proenca; Kevin G Bath; Till Milde; Evgeny Shmelkov; Jared S Kushner; Muhamed Baljevic; Iva Dincheva; Andrew J Murphy; David M Valenzuela; Nicholas W Gale; George D Yancopoulos; Ipe Ninan; Francis S Lee; Shahin Rafii
Journal:  Nat Med       Date:  2010-04-25       Impact factor: 53.440

10.  Genome-wide association study of obsessive-compulsive disorder.

Authors:  S E Stewart; D Yu; J M Scharf; B M Neale; J A Fagerness; C A Mathews; P D Arnold; P D Evans; E R Gamazon; L K Davis; L Osiecki; L McGrath; S Haddad; J Crane; D Hezel; C Illman; C Mayerfeld; A Konkashbaev; C Liu; A Pluzhnikov; A Tikhomirov; C K Edlund; S L Rauch; R Moessner; P Falkai; W Maier; S Ruhrmann; H-J Grabe; L Lennertz; M Wagner; L Bellodi; M C Cavallini; M A Richter; E H Cook; J L Kennedy; D Rosenberg; D J Stein; S M J Hemmings; C Lochner; A Azzam; D A Chavira; E Fournier; H Garrido; B Sheppard; P Umaña; D L Murphy; J R Wendland; J Veenstra-VanderWeele; D Denys; R Blom; D Deforce; F Van Nieuwerburgh; H G M Westenberg; S Walitza; K Egberts; T Renner; E C Miguel; C Cappi; A G Hounie; M Conceição do Rosário; A S Sampaio; H Vallada; H Nicolini; N Lanzagorta; B Camarena; R Delorme; M Leboyer; C N Pato; M T Pato; E Voyiaziakis; P Heutink; D C Cath; D Posthuma; J H Smit; J Samuels; O J Bienvenu; B Cullen; A J Fyer; M A Grados; B D Greenberg; J T McCracken; M A Riddle; Y Wang; V Coric; J F Leckman; M Bloch; C Pittenger; V Eapen; D W Black; R A Ophoff; E Strengman; D Cusi; M Turiel; F Frau; F Macciardi; J R Gibbs; M R Cookson; A Singleton; J Hardy; A T Crenshaw; M A Parkin; D B Mirel; D V Conti; S Purcell; G Nestadt; G L Hanna; M A Jenike; J A Knowles; N Cox; D L Pauls
Journal:  Mol Psychiatry       Date:  2012-08-14       Impact factor: 15.992

View more
  6 in total

1.  Behavioral and synaptic alterations relevant to obsessive-compulsive disorder in mice with increased EAAT3 expression.

Authors:  Claudia Delgado-Acevedo; Sebastián F Estay; Anna K Radke; Ayesha Sengupta; Angélica P Escobar; Francisca Henríquez-Belmar; Cristopher A Reyes; Valentina Haro-Acuña; Elías Utreras; Ramón Sotomayor-Zárate; Andrew Cho; Jens R Wendland; Ashok B Kulkarni; Andrew Holmes; Dennis L Murphy; Andrés E Chávez; Pablo R Moya
Journal:  Neuropsychopharmacology       Date:  2018-12-26       Impact factor: 7.853

2.  (S)-5-(2'-Fluorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine, a Serotonin Receptor Modulator, Possesses Anticonvulsant, Prosocial, and Anxiolytic-like Properties in an Fmr1 Knockout Mouse Model of Fragile X Syndrome and Autism Spectrum Disorder.

Authors:  Jessica L Armstrong; Austen B Casey; Tanishka S Saraf; Munmun Mukherjee; Raymond G Booth; Clinton E Canal
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-21

3.  Neuronal excitatory amino acid transporter EAAT3: Emerging functions in health and disease.

Authors:  Suzanne M Underhill; Susan L Ingram; Susanne E Ahmari; Jeremy Veenstra-VanderWeele; Susan G Amara
Journal:  Neurochem Int       Date:  2018-05-22       Impact factor: 3.921

Review 4.  Bidirectional Behavioral Selection in Mice: A Novel Pre-clinical Approach to Examining Compulsivity.

Authors:  Swarup Mitra; Abel Bult-Ito
Journal:  Front Psychiatry       Date:  2021-09-08       Impact factor: 4.157

5.  Prenatal Poly I:C Challenge Affects Behaviors and Neurotransmission via Elevated Neuroinflammation Responses in Female Juvenile Rats.

Authors:  Yueqing Su; Jiamei Lian; James Hodgson; Wenchang Zhang; Chao Deng
Journal:  Int J Neuropsychopharmacol       Date:  2022-02-11       Impact factor: 5.176

6.  Enhancement of Phosphorylation and Transport Activity of the Neuronal Glutamate Transporter Excitatory Amino Acid Transporter 3 by C3bot and a 26mer C3bot Peptide.

Authors:  Johannes Piepgras; Astrid Rohrbeck; Ingo Just; Stefan Bittner; Gudrun Ahnert-Hilger; Markus Höltje
Journal:  Front Cell Neurosci       Date:  2022-06-15       Impact factor: 6.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.